Transmembrane routes of cationic liposome-mediated gene delivery using human throat epidermis cancer cells

22Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

For studying the mechanism of cationic liposome-mediated transmembrane routes for gene delivery, various inhibitors of endocytosis were used to treat human throat epidermis cancer cells, Hep-2, before transfection with Lipofectamine 2000/pGFP-N2 or Lipofectamine 2000/pGL3. To eliminate the effect of inhibitor toxicity on transfection, the RLU/survival rate was used to represent the transfection efficiency. Chlorpromazine and wortmannin, clathrin inhibitors, decreased transfection efficiency by 44 % (100 μM) and 31 % (100 nM), respectively. At the same time, genistein, a caveolin inhibitor, decreased it by 30 % (200 μM). Thus combined transmembrane routes through the clathrin and caveolae-mediated pathways were major mechanisms of cell uptake for the cationic liposome-mediated gene delivery. After entering the cells, microtubules played an important role on gene delivery as vinblastine, a microtubulin inhibitor, could reduce transfection efficiency by 41 % (200 nM). © 2013 The Author(s).

Cite

CITATION STYLE

APA

Cui, S., Wang, B., Zhao, Y., Chen, H., Ding, H., Zhi, D., & Zhang, S. (2014). Transmembrane routes of cationic liposome-mediated gene delivery using human throat epidermis cancer cells. Biotechnology Letters, 36(1), 1–7. https://doi.org/10.1007/s10529-013-1325-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free